314 related articles for article (PubMed ID: 23126058)
1. [Primary ovarian malignant mixed mesodermal tumor (MMMT) as a second primary tumor in a patient with invasive breast carcinoma--case report].
Sentija K; Bolanca IK; Simon SK; Kukura V; Skrtić A; Gasparov S
Acta Med Croatica; 2011 Sep; 65 Suppl 1():229-34. PubMed ID: 23126058
[TBL] [Abstract][Full Text] [Related]
2. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
4. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
[TBL] [Abstract][Full Text] [Related]
5. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer.
Hubalek M; Ramoni A; Mueller-Holzner E; Marth C
Gynecol Oncol; 2004 Oct; 95(1):264-6. PubMed ID: 15385144
[TBL] [Abstract][Full Text] [Related]
6. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
7. Fine-needle aspiration cytology of metastatic ovarian carcinoma to the breast.
Raptis S; Kanbour AI; Dusenbery D; Kanbour-Shakir A
Diagn Cytopathol; 1996 Jul; 15(1):1-6. PubMed ID: 8807244
[TBL] [Abstract][Full Text] [Related]
8. Malignant mixed müllerian tumors of the ovary.
Wei CF; Hwang SH; Ho CM; Shih BY; Chien TY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):344-8. PubMed ID: 10820916
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery plus intraperitoneal hyperthermic perfusion is an effective treatment for metastasized malignant mixed mesodermal tumours (MMMT)--report of six cases.
Müller H; Nakchbandi V
Eur J Surg Oncol; 2004 Jun; 30(5):573-7. PubMed ID: 15135489
[TBL] [Abstract][Full Text] [Related]
10. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
Malpica A; Deavers MT
Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
[TBL] [Abstract][Full Text] [Related]
11. Ovarian malignant mixed mesodermal tumor with neuroectodermal differentiation: a multifaceted evaluation.
Mott RT; Murphy BA; Geisinger KR
Int J Gynecol Pathol; 2010 May; 29(3):234-8. PubMed ID: 20407321
[TBL] [Abstract][Full Text] [Related]
12. A case of malignant mixed mesodermal tumor (MMMT) of the ovary: MR features before and after chemotherapy.
Kaji Y; Sugimura K; Yamamoto N; Imaoka I; Sugihara M
Radiat Med; 1999; 17(1):81-3. PubMed ID: 10378658
[TBL] [Abstract][Full Text] [Related]
13. Ovarian malignant Mullerian mixed tumor (heterologous) whose epithelial component is composed predominantly of signet ring cell carcinoma.
Terada T
Arch Gynecol Obstet; 2011 Jun; 283(6):1403-6. PubMed ID: 20652287
[TBL] [Abstract][Full Text] [Related]
14. Recurrent breast cancer presents as a single solid ovarian mass and ascites.
Chen P; Hu WM; Wang PH; Suen JH
Taiwan J Obstet Gynecol; 2006 Dec; 45(4):356-9. PubMed ID: 17175500
[TBL] [Abstract][Full Text] [Related]
15. Ascitic fluid cytology in a case of metastatic malignant mixed mesodermal tumor of the ovary.
Silverman JF; Gardner J; Larkin EW; Finley JL; Norris HT
Acta Cytol; 1986; 30(2):173-6. PubMed ID: 3457508
[TBL] [Abstract][Full Text] [Related]
16. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.
Spieler P; Gloor F
Acta Cytol; 1985; 29(5):753-67. PubMed ID: 2996273
[TBL] [Abstract][Full Text] [Related]
17. Metastasis of breast carcinoma to a primary mucinous cystadenocarcinoma of the ovary.
Twaalfhoven FC; Fleuren GJ; Cornelisse CJ; Peters AA; Trimbos JB; Hogendoorn PC
Gynecol Oncol; 1994 Jan; 52(1):80-6. PubMed ID: 8307506
[TBL] [Abstract][Full Text] [Related]
18. Malignant mixed mesodermal ovarian tumor treatment and prognosis: a 20-year experience.
Le T; Krepart GV; Lotocki RJ; Heywood MS
Gynecol Oncol; 1997 May; 65(2):237-40. PubMed ID: 9159331
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous endometrial malignant mixed mesodermal tumor and ovarian serous adenocarcinoma.
Krigman HR; Coogan AC; Marks JR
Arch Pathol Lab Med; 1995 Jan; 119(1):99-103. PubMed ID: 7802567
[TBL] [Abstract][Full Text] [Related]
20. Breast metastasis 56 months before the diagnosis of primary ovarian cancer: a case study.
Schneuber SE; Scholz HS; Regitnig P; Petru E; Winter R
Anticancer Res; 2008; 28(5B):3047-50. PubMed ID: 19031954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
